Molecular Mechanisms Involved in Interleukin-1β Release by Macrophages Exposed to Metal Ions from Implantable Biomaterials
| dc.contributor.author | Ferko, Maxime-Alexandre | |
| dc.contributor.supervisor | Catelas, Isabelle | |
| dc.date.accessioned | 2018-03-23T18:27:32Z | |
| dc.date.available | 2018-03-23T18:27:32Z | |
| dc.date.issued | 2018 | |
| dc.description.abstract | Metal ions released from implantable biomaterials have been associated with adverse biological reactions that can limit implant longevity. Previous studies have shown that, in macrophages, Co2+, Cr3+, and Ni2+ can activate the NLR family pyrin domain-containing protein 3 (NLPR3) inflammasome, which is responsible for interleukin(IL)-1β production through caspase-1. Furthermore, these ions are known to induce oxidative stress, and inflammasome priming is known to involve nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling. However, the mechanisms of inflammasome activation by metal ions remain largely unknown. The objectives of this thesis were to determine if, in macrophages: 1. IL-1β release induced by metal ions is caspase-1-dependent; 2. caspase-1 activation and IL-1β release induced by metal ions are oxidative stress-dependent; and 3. IL-1β release induced by metal ions is NF-κB signaling pathway-dependent. Lipopolysaccharide (LPS)-primed murine bone-marrow-derived macrophages were exposed to Co2+, Cr3+, or Ni2+, with or without an inhibitor of caspase-1, oxidative stress, or NF-κB. Culture supernatants were analyzed for active caspase-1 (immunoblotting) and/or IL-1β (ELISA). Overall, results showed that while both Cr3+ and Ni2+ may be inducing inflammasome activation, Cr3+ is likely a more potent activator, acting through oxidative stress and the NF-κB signaling pathway. Further elucidation of the activation mechanisms may facilitate the development of therapeutic approaches to modulate the inflammatory response to metal ions, and thereby increase implant longevity. | en |
| dc.identifier.uri | http://hdl.handle.net/10393/37331 | |
| dc.identifier.uri | http://dx.doi.org/10.20381/ruor-21603 | |
| dc.language.iso | en | en |
| dc.publisher | Université d'Ottawa / University of Ottawa | en |
| dc.subject | bioengineering | en |
| dc.subject | biomedical engineering | en |
| dc.subject | biomaterials | en |
| dc.subject | biocompatibility | en |
| dc.subject | orthopaedics | en |
| dc.subject | implants | en |
| dc.subject | metal alloys | en |
| dc.subject | metal ions | en |
| dc.subject | adverse tissue reactions | en |
| dc.subject | immune response | en |
| dc.subject | inflammation | en |
| dc.subject | molecular mechanisms | en |
| dc.subject | inflammasome activation | en |
| dc.subject | NLRP3 | en |
| dc.subject | NALP3 | en |
| dc.subject | macrophages | en |
| dc.subject | bone marrow-derived macrophages | en |
| dc.title | Molecular Mechanisms Involved in Interleukin-1β Release by Macrophages Exposed to Metal Ions from Implantable Biomaterials | en |
| dc.type | Thesis | en |
| thesis.degree.discipline | Génie / Engineering | en |
| thesis.degree.level | Masters | en |
| thesis.degree.name | MASc | en |
| uottawa.department | Génie chimique et biologique / Chemical and Biological Engineering | en |
